141 related articles for article (PubMed ID: 16965389)
21. PECAM-1 modulates thrombin-induced tissue factor expression on endothelial cells.
Zhang JJ; Kelm RJ; Biswas P; Kashgarian M; Madri JA
J Cell Physiol; 2007 Feb; 210(2):527-37. PubMed ID: 17111362
[TBL] [Abstract][Full Text] [Related]
22. Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies.
Del Papa N; Sheng YH; Raschi E; Kandiah DA; Tincani A; Khamashta MA; Atsumi T; Hughes GR; Ichikawa K; Koike T; Balestrieri G; Krilis SA; Meroni PL
J Immunol; 1998 Jun; 160(11):5572-8. PubMed ID: 9605162
[TBL] [Abstract][Full Text] [Related]
23. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
Pierangeli SS; Harris EN
Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
[TBL] [Abstract][Full Text] [Related]
24. Anti-beta 2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells.
Kornberg A; Renaudineau Y; Blank M; Youinou P; Shoenfeld Y
Isr Med Assoc J; 2000 Jul; 2 Suppl():27-31. PubMed ID: 10909414
[TBL] [Abstract][Full Text] [Related]
25. E-Selectin mediates pathogenic effects of antiphospholipid antibodies.
Espinola RG; Liu X; Colden-Stanfield M; Hall J; Harris EN; Pierangeli SS
J Thromb Haemost; 2003 Apr; 1(4):843-8. PubMed ID: 12871424
[TBL] [Abstract][Full Text] [Related]
26. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties.
Abid Hussein MN; Böing AN; Biró E; Hoek FJ; Vogel GM; Meuleman DG; Sturk A; Nieuwland R
Thromb Res; 2008; 121(6):865-71. PubMed ID: 17889282
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in the 5'-UTR of the tissue factor gene are associated with altered expression in human endothelial cells.
Terry CM; Kling SJ; Cheang KI; Hoidal JR; Rodgers GM
J Thromb Haemost; 2004 Aug; 2(8):1351-8. PubMed ID: 15304041
[TBL] [Abstract][Full Text] [Related]
28. Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?
Cavazzana I; Manuela N; Irene C; Barbara A; Sara S; Orietta BM; Angela T; Francesco T; Luigi MP
J Autoimmun; 2007; 28(2-3):160-4. PubMed ID: 17419007
[TBL] [Abstract][Full Text] [Related]
29. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
30. Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome.
Zhou H
Acta Pharmacol Sin; 2004 Oct; 25(10):1366-71. PubMed ID: 15456541
[TBL] [Abstract][Full Text] [Related]
31. Desmopressin (DDAVP) enhances platelet adhesion to the extracellular matrix of cultured human endothelial cells through increased expression of tissue factor.
Gálvez A; Gómez-Ortiz G; Díaz-Ricart M; Escolar G; González-Sarmiento R; Zurbano MJ; Ordinas A; Castillo R
Thromb Haemost; 1997 May; 77(5):975-80. PubMed ID: 9184413
[TBL] [Abstract][Full Text] [Related]
32. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo.
Pierangeli SS; Colden-Stanfield M; Liu X; Barker JH; Anderson GL; Harris EN
Circulation; 1999 Apr; 99(15):1997-2002. PubMed ID: 10209004
[TBL] [Abstract][Full Text] [Related]
33. Induction of procoagulant function in porcine endothelial cells by human natural killer cells.
Malyguine AM; Saadi S; Holzknecht RA; Patte CP; Sud N; Platt JL; Dawson JR
J Immunol; 1997 Nov; 159(10):4659-64. PubMed ID: 9366388
[TBL] [Abstract][Full Text] [Related]
34. [Inhibition of tissue factor expression in endothelial cells by lentivirus mediated shRNA].
Xiong SL; Wang Q; Zheng L; Bao J; Huang XZ; Liu JZ; Zeng FY; Qiu YR
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):682-7. PubMed ID: 18772506
[TBL] [Abstract][Full Text] [Related]
35. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?
Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW
Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152
[TBL] [Abstract][Full Text] [Related]
36. Andrographolide inhibits NF-kappaBeta activation and attenuates neointimal hyperplasia in arterial restenosis.
Wang YJ; Wang JT; Fan QX; Geng JG
Cell Res; 2007 Nov; 17(11):933-41. PubMed ID: 17943075
[TBL] [Abstract][Full Text] [Related]
37. Tissue factor in the antiphospholipid syndrome.
Kinev AV; Roubey RA
Lupus; 2008 Oct; 17(10):952-8. PubMed ID: 18827061
[TBL] [Abstract][Full Text] [Related]
38. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
39. Andrographolide inhibits the adhesion of gastric cancer cells to endothelial cells by blocking E-selectin expression.
Jiang CG; Li JB; Liu FR; Wu T; Yu M; Xu HM
Anticancer Res; 2007; 27(4B):2439-47. PubMed ID: 17695536
[TBL] [Abstract][Full Text] [Related]
40. [Hemangiopoiet in modulates adhesive properties of endothelial cells].
Wang XJ; Liu YJ; Lu SH; Liang LH; Wang H; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):364-7. PubMed ID: 16900634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
